Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Celecoxib × 1 year × Clear all

Sponsor

Conditions

Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Recurrence 2 Medulloblastoma 2 Ependymoma 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Rectal Neoplasms 1 Pinealoma 1 Peutz-Jeghers Syndrome 1 Pancreatic Cancer Metastatic 1 Ovarian Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Mouth Neoplasms 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Histiocytosis, Langerhans-Cell 1 Glioma 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breast Neoplasms 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 tetrathiomolybdate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡